Sweden Life Sciences Trend Analysis 2015
After the best venture financing of Swedish Biotechnology Company of the last 5 years in 2014, the venture financing goes back to previous level in 2015 to date. The pipeline is maturing and renewing at the same time, with the number of products in phase II similar to the number of product in preclinical studies.
Looking for your next Biotech or Medtech partner?
Use Biotechgate to identify new leads, licensing opportunities and management details.